Kang, J., Korecka, M., Toledo, J. B., Trojanowski, J. Q., & Shaw, L. M. (2013). Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β(1–42) and τ Proteins as Alzheimer Disease Biomarkers.
シカゴスタイル引用形Kang, Ju-Hee, Magdalena Korecka, Jon B. Toledo, John Q. Trojanowski, , Leslie M. Shaw. Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β(1–42) and τ Proteins As Alzheimer Disease Biomarkers. 2013.
MLA引用形式Kang, Ju-Hee, et al. Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β(1–42) and τ Proteins As Alzheimer Disease Biomarkers. 2013.
警告: この引用は必ずしも正確ではありません.